Clinical Trials Browser

Phase 2 × apatinib × Genitourinary × Clear all

NCT04869488 2025-01-24

A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 2 Completed

Metastatic Castration Resistant Prostate Cancer

NCT02774200 2016-05-17

A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.

Phase 2 Unknown

Carcinoma, Renal Cell